VXRT OTC
Vaxart, Inc.
1W: -3.9%
1M: -10.9%
3M: -29.2%
YTD: +21.4%
1Y: +15.0%
3Y: -39.3%
5Y: -94.7%
$0.44
-0.00 (-0.68%)
Weekly Expected Move ±5.1%
$0
$0
$0
$0
$0
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Supply Chain Overview
15 relationships15
As Filer
counterparties named
0
As Counterparty
mentioned by others
6
Rel. Types
2021-09-21
Earliest Filing
2025-11-05
Latest Filing
partner: 7
acquirer: 3
customer: 2
target: 1
investor: 1
supplier: 1
Counterparties (Filed by VXRT)
15 relationshipsCompanies named in VXRT's SEC 8-K filings as business counterparties.
| Counterparty | Ticker | Relationship | Summary | Filing Date | SEC |
|---|---|---|---|---|---|
| Dynavax Technologies Corporation | DVAX | acquirer | Dynavax acquired an exclusive worldwide license to Vaxart's oral COVID-19 vaccine program and made an equity investment. | 2025-11-05 | View |
| Vaxart, Inc. | VXRT | target | Vaxart granted an exclusive worldwide license to Dynavax for its oral COVID-19 vaccine candidate and received an upfront | 2025-11-05 | View |
| Advanced Technology International | — | partner | Consortium Base Agreement partner that issued a stop work order regarding Project Agreement No. 01. | 2025-08-06 | View |
| Advanced Technology International | — | partner | Consortium Management Firm for the Project Agreement with BARDA | 2025-04-28 | View |
| Biomedical Advanced Research and Development Authority | — | partner | Government agency funding the Project Agreement | 2025-04-28 | View |
| Advanced Technology International | — | partner | Consortium Management Firm for the Project Agreement with BARDA that issued stop work orders to the Company. | 2025-02-24 | View |
| Vaxart, Inc. | VXRT | acquirer | Company issuing securities in this agreement | 2024-01-16 | View |
| RA Capital Healthcare Fund, L.P. | — | investor | Purchaser of securities in this agreement | 2024-01-16 | View |
| Cantor Fitzgerald & Co. | — | partner | Acting as representative of the underwriters for the sale of 16,000,000 shares of common stock. | 2023-06-08 | View |
| hVIVO Services Limited | — | partner | Contract research organization (CRO) to conduct characterization and Omicron human challenge studies | 2022-07-06 | View |
| Open Orphan plc | ORPH | partner | Parent company of hVIVO Services Limited | 2022-07-06 | View |
| Kindred Bioscience, Inc. | — | acquirer | Vaxart acquired KindredBio's manufacturing equipment and subleased its GMP facility. | 2021-12-01 | View |
| BRITANNIA POINTE GRAND LIMITED PARTNERSHIP | — | supplier | Landlord leasing business park premises | 2021-09-21 | View |
| VAXART, INC. | VXRT | customer | Tenant leasing business park premises | 2021-09-21 | View |
| VERA THERAPEUTICS, INC. | VERA | customer | Sublandlord in prior sublease agreement | 2021-09-21 | View |
Recent 8-K Filings (20)
| Filing Date | Description | Type | SEC |
|---|---|---|---|
| 2026-09-14 | Other Events | View | |
| 2026-08-25 | Other Events | View | |
| 2026-08-06 | Earnings Release; Exhibits | View | |
| 2026-07-28 | Other Events | View | |
| 2026-07-17 | Shareholder Vote; Regulation FD; Exhibits | View | |
| 2026-07-07 | Other Events; Exhibits | View | |
| 2026-07-02 | Material Agreement; Regulation FD; Exhibits | Agreement | View |
| 2026-06-26 | Material Agreement; Other Events; Exhibits | Agreement | View |
| 2026-05-19 | Other Events; Exhibits | View | |
| 2026-05-07 | Earnings Release; Exhibits | View | |
| 2026-04-23 | Officer/Director Change; Regulation FD; Exhibits | View | |
| 2026-04-21 | Other Events | View | |
| 2026-04-17 | Material Agreement; Unregistered Equity Sales; Regulation FD; Exhibits | Agreement | View |
| 2026-03-12 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-12-29 | Termination of Material Definitive Agreement | View | |
| 2025-11-13 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-11-05 | Entry into Material Definitive Agreement; Regulation FD Disclosure; Financial Statements and Exhibit | Agreement | View |
| 2025-10-10 | Regulation FD Disclosure | View | |
| 2025-09-19 | Notice of Delisting or Transfer | View | |
| 2025-09-19 | Other Events | View |
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text.
Covers 2021–2026. View on SEC EDGAR